anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Title

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 303,780
Current window 240,751-240,780
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all
18 30 60

Component

240,751-240,780 of 303,780

filter-aware
07
The chart illustrates a shift in revenue seasonality from Q1/Q2 towards Q4 for the 2016 fiscal year.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Need1 hit
08
The slide uses a staggered block layout to represent chronological development of various software platforms.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Satisfaction1 hit
09
The slide uses a visual timeline to show the progression of various platform products from the early 2000s to the current state, with CARA highlighted as a key recent development.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Satisfaction1 hit
10
The diagram uses a staggered block layout to represent the growth of product offerings over time, with blue boxes highlighting current key innovations.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Satisfaction1 hit
11
The slide illustrates a hybrid cloud architecture with load balancing across private and public environments.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Satisfaction1 hit
12
The chart uses a non-linear, illustrative scale to show performance multipliers (2x to 15x) against patient counts.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The chart is a classic waterfall bridge showing the impact of platform mix, price, and efficiency on gross margin.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
20
The slide uses a waterfall chart to bridge the gap between 2015 and 2016 EBITDA margins.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
21
Includes a footnote regarding an undrawn $100 million revolving credit facility.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Visualization1 hit
01
Slide 1
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
02
Standard regulatory disclaimer for medical device presentations.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
03
Includes a mandatory FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
06
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
07
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
08
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
09
Includes a disclaimer at the bottom regarding FDA status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
10
Includes a standard Theranos FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
11
The slide showcases hardware components for clinical chemistry, immunochemistry, hematology/immunology, and molecular biology.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
12
The slide displays six distinct hardware components: Camera, Material Handling Robot, Cartridge, Sonicator, Thermocycler, and Centrifuge.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
13
The slide includes a disclaimer about FDA clearance status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
14
The slide includes a disclaimer about FDA approval status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
15
Includes a disclaimer regarding FDA clearance status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
16
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
17
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
18
The slide includes a standard FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
19
The slide includes a disclaimer about FDA status at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
22
The slide includes a disclaimer at the bottom regarding FDA approval status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
26
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
27
The slide is a frame from a video presentation showing the internal mechanics of a blood testing device.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
28
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit